A recent perspective offered guidance to clinician’s in managing how or in some cases whether to disclose a diagnosis of ...

BioArctic AB's (publ) (NASDAQ: BIOA B) (STOCKHOLM: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia has declined the approval of lecanemab (generic ...

Read this article to learn how to initiate an assessment for dementia in primary care, acute care and care homes.

BioArctic AB's (publ) (NASDAQ: BIOA B) (STOCKHOLM: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia ...

In October 2024, the TGA made the decision not to register lecanemab (LEQEMBI) on the Australian Register of Therapeutic Goods (ARTG) for the ...

There are very few diagnoses that evoke more fear and apprehension than dementia. The idea of losing one’s mind—the very ...

Discover the benefits of a plant-based diet, from reduced inflammation and improved heart health to reduced risk of certain cancers. Learn more!

A new study suggests that wearing dentures may help slow cognitive decline in older adults who have lost some or all of their ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

The second most horrible thing about being scammed is the ridicule from others.

Longevity researchers often look to older populations to unearth the secrets of those who age exceptionally well. Now social ...